| Chapter : The Role of Apolipoprotein E in the Pathological Events Following Subarachnoid Hemorrhage: A Review | 15 |
|---|
| Introduction | 15 |
| APOE and Outcome After SAH | 15 |
| ApoE and Early Brain Injury After SAH | 16 |
| ApoE and Cerebral Vasospasm After SAH | 16 |
| Conclusion | 16 |
| References | 16 |
| Chapter : Mechanisms of Statin Treatment in Cerebral Vasospasm | 18 |
|---|
| Introduction | 18 |
| Materials and Methods | 19 |
| Results | 19 |
| Conclusion | 20 |
| References | 20 |
| Chapter : The Effect of Phosphodiesterase Inhibitor Tadalafil on Vasospasm Following Subarachnoid Hemorrhage in an Experimental | 21 |
|---|
| Introduction | 21 |
| Methods and Materials | 22 |
| Animal Model | 22 |
| Induction of Experimental SAH | 22 |
| Perfusion-Fixation | 22 |
| Embedding, Morphometry, and Statistical Analysis | 22 |
| Results | 22 |
| Discussion | 23 |
| References | 24 |
| Chapter : Effect of a Free Radical Scavenger, Edaravone, on Free Radical Reactions: Related Signal Transduction and Cerebral Va | 25 |
|---|
| Introduction | 25 |
| Materials and Methods | 26 |
| Production of SAH | 26 |
| Intravenous Injection of Edaravone | 26 |
| Histological Evaluation | 26 |
| Western Blotting | 26 |
| Statistical Analysis | 26 |
| Results | 27 |
| Evaluation of Cerebral Vasospasm (Figs. 1 and 2) | 27 |
| Expression of Rho-kinase (Fig. 3) | 27 |
| Discussion | 28 |
| Conclusion | 29 |
| References | 29 |
| Chapter : Comparison of Nimodipine Delivery Routes in Cerebral Vasospasm After Subarachnoid Hemorrhage: An Experimental Study i | 31 |
|---|
| Introduction | 31 |
| Materials and Methods | 31 |
| Animal Groups | 31 |
| Nimodipine Solution | 32 |
| SAH Formation | 32 |
| Angiography Procedure | 32 |
| Perfusion-Fixation | 32 |
| Neurological Parameters | 32 |
| Embedding, Morphometry, and Statistical Analysis | 33 |
| Results | 33 |
| Pathological Measurements | 33 |
| Mortality and Neurological Parameters | 33 |
| Angiographic Measurements | 34 |
| Discussion | 35 |
| Conclusion | 36 |
| References | 36 |
| Chapter : Effect of Recombinant Osteopontin on Cerebral Vasospasm After Subarachnoid Hemorrhage in Rats | 37 |
|---|
| Introduction | 37 |
| Materials and Methods | 37 |
| Experimental Model of SAH and Study Protocol | 37 |
| Neurological Scoring | 38 |
| India Ink angiography | 38 |
| Severity of SAH | 38 |
| Intracerebroventricular Infusion | 38 |
| Statistics | 39 |
| Results | 39 |
| Conclusion | 39 |
| References | 40 |
| Chapter : The Effect of Intracisternal Zn (II) Protoporphyrin IX on Vasospasm Process in the Experimental Subarachnoid Hemorrha | 41 |
|---|
| Introduction | 41 |
| Methods and Materials | 42 |
| Animal Model | 42 |
| Induction of Experimental SAH | 42 |
| Perfusion-Fixation | 42 |
| Embedding, Morphometry, and Statistical Analysis | 42 |
| Results | 42 |
| Discussion | 43 |
| References | 44 |
| Chapter : Temporal Profile of the Effects of Intracisternal Injection of Magnesium Sulfate Solution on Vasodilation of Spastic | 46 |
|---|
| Introduction | 46 |
| Materials and Methods | 47 |
| Results | 47 |
| Temporal Profile of Changes in CSF Mg2+ and Ca2+ Concentrations | 47 |
| Temporal Profile of Neuroimaging Changes | 48 |
| Conclusion | 48 |
| References | 49 |
| Chapter : Comparison of Intrathecal Cilostazol and Nimodipine Treatments in Subarachnoid Hemorrhage: An Experimental Study in R | 50 |
|---|
| Introduction | 50 |
| Methods and Materials | 51 |
| Induction of SAH | 51 |
| Experimental Protocol | 51 |
| Statistical Analysis | 52 |
| Results | 52 |
| Discussion | 52 |
| Conclusion | 54 |
| References | 55 |
| Chapter : Blocking Cerebral Lymphatic Drainage Deteriorates Cerebral Oxidative Injury in Rats with Subarachnoid Hemorrhage | 56 |
|---|
| Introduction | 56 |
| Materials and Methods | 56 |
| Animal Preparations | 56 |
| Arterial Blood Gas and Blood Pressure Monitoring | 57 |
| Serum Lactate Dehydrogenase Activity Detection | 57 |
| Detection of Brain Tissue Superoxide Dismutase Activity and Malonaldehyde Content | 57 |
| Statistical Analysis | 57 |
| Results | 58 |
| Behavior Observation and SAH Models Verification | 58 |
| Arterial Blood Gas and Blood Pressure | 58 |
| Serum Lactate Dehydrogenase Activity | 58 |
| Brain Tissue Superoxide Dismutase Activity and Malonaldehyde Content | 58 |
| Discussion | 58 |
| References | 59 |
| Chapter : Comparison of Intrathecal Dotariz
|